Navigation Links
Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2014
Date:7/25/2013

call will be available by visiting http://www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10031352, through August 1, 2013.  This press release is also available prior to and after the call via Abaxis' website or the Securities and Exchange Commission's website at http://www.sec.gov

About AbaxisAbaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.  For more information, visit http://www.abaxis.com.

Use of Financial MeasuresTo supplement the financial statements presented in accordance with United States generally accept
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
3. Abaxis To Report First Quarter Fiscal Year 2013 Financial Results Thursday, July 26, 2012
4. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
5. Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
7. Abaxis, Inc. to Present at CL Kings 10th Annual Best Ideas Conference 2012
8. Abaxis, Inc. to Present at UBS Global Life Sciences Conference
9. Abaxis Announces the Launch of Kidney Profile Plus Panel
10. Abaxis Announces Exclusive Distribution Agreement with Abbott
11. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... a leader in R&D for new therapeutic solutions for the ... Growth Factor) has been designated as an orphan drug by ... The candidate drug, developed by the research of Dompe, has ... neurotrophic keratitis, a degenerative corneal disease that affects less than ... a cure. This is the second orphan drug designation by ...
(Date:7/23/2014)... July 23, 2014 Research and ... "Prepackaged Medical Kits and Trays - Global ... http://photos.prnewswire.com/prnh/20130307/600769 ... Prepackaged Medical Kits and Trays in US$ Thousands ... Ophthalmic Custom Trays, Custom Basin Kits, Custom Ob/Gyn ...
(Date:7/23/2014)...  ArmaGen, a privately held biotechnology company focused ... disorders, announced today that it has entered into ... plc to develop AGT-182, an investigational enzyme replacement ... central nervous system (CNS) and somatic (body-related) manifestations ... Hunter syndrome is a rare, severe, progressive and ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3
... VacChina 2011 - - ... - - welcomes world class ... vaccine R&D and manufacturing technologies in China. The ... national regulatory authority of China -- the State Food and Drug ...
... Aug. 18, 2011 Generex Biotechnology Corporation (OTCBB: ... Company,s wholly-owned subsidiary Antigen Express, Inc. ( www.antigenexpress.com ... 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, ... Healthtech Institute,s Sixth Annual ImVacS: The Immunotherapeutics and ...
Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4
(Date:7/23/2014)... 23, 2014 SafeUseNow? , ... program developed by Principled Strategies , today ... of California . Utilizing SafeUseNow’s patent-pending risk model, ... of misusing and abusing controlled substance drugs, particularly ... among its members. , The agreement with Partnership ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The European ... fertilizers market in Europe with analysis and forecast of ... to grow from around $ 2,566.4 million in 2012 ... 12.3%, from 2012 to 2017. , Browse through the ... get an idea of the in-depth analysis provided. ...
(Date:7/23/2014)... workplaces may need to consider innovative methods to prevent ... on results from a new study published in the ... JOEH ), workers who are obese may have significantly ... their non-obese counterparts. , The study, conducted at ... 32 individuals in four categories (non-obese young, obese young, ...
(Date:7/23/2014)... athletes who suffered repeated blows to the head during ... Those clumps suggest the athletes had a disease called ... tests that might be able to detect CTE in ... Chemical & Engineering News (C&EN) , the weekly news ... article, Lauren Wolf, a senior editor at C&EN, explains ...
(Date:7/23/2014)... Jose, CA (PRWEB) July 23, 2014 ... computing and collaboration, today announce that it has ... has established interoperability between Splashtop Enterprise and RSA ... Division of EMC (EMC). , Splashtop ... Asset Management is now deploying Splashtop Enterprise, the ...
Breaking Medicine News(10 mins):Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Obesity linked to low endurance, increased fatigue in the workplace 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3
... several previous studies, Geoffrey R. Howe, Ph.D., of Columbia ... that exposure// to radioactive substances increased cancer risks in ... a study conducted to examine the cancer prevalence showed ... adolescents who are exposed to radioactive iodine. ...
... Medical Association (AMA) has issued a warning that the nation ... due to a lack of clinical expertise. ,Dr ... MPs and senators insisting for a strategy be put in ... number of students. He stated that there would be a ...
... show that the number of sexually transmitted infections is on ... 2005 there was a 3 percent rise in the diagnosis ... increase was reported in syphilis cases at 23 percent, but ... cases of gonorrhea fell by 13 percent. The highest increase ...
... that inhabitants of Phet where hundreds of poultry died last ... a feast on these birds. ,Public health officials ... create awareness of bird flu after hundreds of chicken died ... after a visit to the area that people were disregarding ...
... Kalam, who is on a three-day visit to Orissa, was ... the state board examination despite suffering// from an eye disorder ... the Bhubaneswar Eye Institute (BEI) located on the outskirts of ... and hoped doctors of the institute would find a cure. ...
... and biological timing in the body work much differently ... approach to making drugs for sleep disorders and depression ... an about-face from previous research, said Daniel Forger, assistant ... and his collaborators from the University of Utah's Huntsman ...
Cached Medicine News:Health News:Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine 2Health News:New Sleep Gene Discovery Wakes Up Scientists 2
Townsend is a endocervical stainless-steel curette with round tapered tip....
...
...
...
Medicine Products: